Named on one round in the feed.
Since 2024-06-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $55M | 2024-06-14 | [ PART ] |